v3.22.2.2
Note 3 - Merger with Old Cytocom - Purchase Price - Assets Acquired and Liabilities Assumed (Details) (Parentheticals)
Jul. 27, 2021
Panacela [Member] | Cleveland BioLabs, Inc. [Member]  
Ownership percentage 67.57%